https://www.selleckchem.com/pr....oducts/conteltinib-c
505-92.183; P = 0.003) and Onyx volume ≥ 6 ml (OR 1.138; 95% CI, 1.006-1.288; P = 0.04 were significant factors associated with these hemorrhagic complications. Hemorrhagic complications associated with endovascular DAVF embolization are not negligible. The pial arterial supplier, giant venous aneurysm and higher Onyx volume in one session may be risk factors for endovascular DAVF embolization. Hemorrhagic complications associated with endovascular DAVF embolization are not negligible. The pial arterial supplier, giant veno
Like
Comment
Share
